Skip to main content


A Whole-Person Approach to Mental Health

Christina Mainelli ’11, CEO of Quartet Health, explains how the company solves bottlenecks around access, quality, and fragmentation to deliver whole person care.

Acolorful illustration of a woman's face
  • Going the Last Mile (with Evidence)

    A study by Yale’s Mushfiq Mobarak and his colleagues found that nurses on motorbikes with vaccine-stocked coolers could help increase vaccination rates in rural Sierra Leone, showing that it is possible to get health interventions to the most remote and under-resourced areas cost-effectively, in ways that help ensure that the interventions are taken up and used.

    A motorcycle carrying vaccine supplies along a dirt road
  • How a Time Out Can Help Address Bias

    The Bias Time Out, developed by a team including Gina Calder ’22 and Dr. Cecelia Calhoun ’21, helps healthcare teams spot and address bias in real time.

    An illustration of doctors and nurses discussing care in surgery
  • In the Emergency Department, Patients from Marginalized Groups Are More Likely to be Bypassed in the Queue

    In a busy hospital emergency department, White people who speak English and have private insurance are more likely to jump the line and get seen first, according to new research from Professors Lesley Meng and Edieal Pinker and Dr. Rohit Sangal ’21 of Yale New Haven Hospital.

    Patients waiting in an emergency department waiting room
  • The Dark Side of an Idealized Picture of Nursing

    A new ethnographic study from Yale SOM’s Julia DiBenigno illustrates how a focus by workers on a fantasy version of their job can get in the way of organizational goals.

    A fuzzy images of nurses with a patient
  • Collaboration Can Close Healthcare Gaps—But It Isn’t Easy

    Collaboration among organizations and across sectors can help, said a group of leaders at the Yale Healthcare Conference—but it must be pursued strategically.

    Staff at a mobile clinic in Seattle in April 2020. 
  • Has the CRISPR Revolution Arrived Yet?

    The first drugs using the CRISPR technique are approaching the market, with the potential to transform the lives of people with certain genetic illnesses. We talked with Dr. Greg Licholai about the state of the technology.

    Confocal Fluorescence Microscopy of CRISPR-generated knockout cells. 
  • Uncovering the Mental Health Impacts of COVID-19 in Low- and Middle-Income Countries

    A new study co-authored by Yale SOM’s Mushfiq Mobarak investigated how mental health fared after the pandemic arrived in eight low- and middle-income countries, and found signs of a sharp, and lasting, deterioration.

    A COVID-19 patient is taken to a hospital in Dhaka, Bangladesh, in July 2021.
  • A Long-Term Solution to Insuring the Sick

    In a new paper, Yale SOM’s Soheil Ghili and his co-authors show that longer health insurance contracts could protect consumers who are or become ill against sudden premium spikes.

    A patient in a hospital bed with a nurse looking at a rolling monitor
  • The Role of Business after Roe

    In the wake of the Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision, access to reproductive healthcare varies widely from state to state. In a recent Yale SOM conversation, alumni and faculty discussed how businesses can advocate for the preservation of that access on behalf of their employees, customers, and other stakeholders.

    Pro-choice protesters
  • Can the Inflation Reduction Act Bring Down Drug Prices?

    We asked Prof. Fiona Scott Morton, an expert on competition in the healthcare industry, whether the new legislation will make a difference—and what it will take to get drug prices under control.

    An elderly customer at a pharmacy window